Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease–mineral and bone disorder

被引:1
作者
Barbara Santarosa Emo Peters
Rosa Maria Affonso Moyses
Vanda Jorgetti
Lígia Araújo Martini
机构
[1] University of Sao Paulo,Department of Nutrition, School of Health Public
[2] University of Sao Paulo,Nephrology Division, School of Medicine
来源
International Urology and Nephrology | 2007年 / 39卷
关键词
Chronic renal failure; Hemodialysis; Parathyroidectomy; Chronic kidney disease–mineral and bone disorder; Osteoprotegerin; Tartrate-resistant acid phosphatase isoform 5b; Vitamin D;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1251 / 1256
页数:5
相关论文
共 94 条
[1]  
Amann K(1999)Hyperphosphataemia—a silent killer of patients with renal failure? Nephrol Dial Transplant 14 2085-2087
[2]  
Gross ML(1997)Hyperparathyroidism in the hemodialysis population: a survey of 612 patients Am J Kidney Dis 29 862-865
[3]  
London GM(2003)Influence of PTH assay methodology on differential diagnosis of renal bone disease Nephrol Dial Transplant 18 759-768
[4]  
Ritz E(2003)Parathyroidectomy: who and when? Kidney Int 63 S97-S100
[5]  
Salem MM(2003)Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorpition Anticancer Res 23 1027-1029
[6]  
Reichel H(2001)Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity Clin Chem 47 74-80
[7]  
Esser A(2003)Introduction: recent advances in TRAP/PAP biochemistry, molecular biology, and clinical application J Bone Miner Res 18 1892-1893
[8]  
Hoth HJ(1997)Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309-319
[9]  
Schmidt-Gayk H(2002)Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure Am J Kidney Dis 39 525-532
[10]  
Jofré R(2002)Serum osteoprotegerin and renal osteodystrophy Nephrol Dial Transplant 17 233-238